| First Author | Sakai T | Year | 2007 |
| Journal | J Biol Chem | Volume | 282 |
| Issue | 3 | Pages | 2038-46 |
| PubMed ID | 17082193 | Mgi Jnum | J:118547 |
| Mgi Id | MGI:3699760 | Doi | 10.1074/jbc.M608144200 |
| Citation | Sakai T, et al. (2007) Skp2 controls adipocyte proliferation during the development of obesity. J Biol Chem 282(3):2038-46 |
| abstractText | The increase in the mass of adipose tissue during the development of obesity can arise through an increase in cell size, an increase in cell number, or both. Here we show that long term maintenance of C57BL/6 mice on a high fat diet (for approximately 25 weeks) induces an initial increase in adipocyte size followed by an increase in adipocyte number in white adipose tissue. The latter effect was found to be accompanied by up-regulation of expression of the gene for the F-box protein Skp2 as well as by downregulation of the cyclin-dependent kinase inhibitor p27(Kip1), a principal target of the SCF(Skp2) ubiquitin ligase, in white adipose tissue. Ablation of Skp2 protected mice from the development of obesity induced either by a high fat diet or by the lethal yellow agouti (A(y)) mutation, and this protective action was due to inhibition of the increase in adipocyte number without an effect on adipocyte hypertrophy. The reduction in the number of adipocyte caused by Skp2 ablation also inhibited the development of obesity-related insulin resistance in the A(y) mutant mice, although the reduced number of beta cells and reduced level of insulin secretion in Skp2-deficient mice resulted in glucose intolerance. Our observations thus indicate that Skp2 controls adipocyte proliferation during the development of obesity. |
